These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24086139)

  • 41. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction.
    Yang Y; Brandariz-Nuñez A; Fricke T; Ivanov DN; Sarnak Z; Diaz-Griffero F
    Virology; 2014 Jan; 448():217-28. PubMed ID: 24314652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection.
    Humes D; Emery S; Laws E; Overbaugh J
    J Virol; 2012 Dec; 86(23):12472-83. PubMed ID: 22973036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
    Rold CJ; Aiken C
    PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
    Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
    J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct combinations of amino acid substitutions in N-terminal domain of Gag-capsid afford HIV-1 resistance to rhesus TRIM5α.
    Nomaguchi M; Nakayama EE; Yokoyama M; Doi N; Igarashi T; Shioda T; Sato H; Adachi A
    Microbes Infect; 2014 Nov; 16(11):936-44. PubMed ID: 25195168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Solis GP; Ikeda Y
    J Biol Chem; 2010 Nov; 285(45):34508-17. PubMed ID: 20810659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques.
    Tipper C; Sodroski JG
    J Virol; 2014 Sep; 88(18):10289-302. PubMed ID: 24991000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
    Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
    J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors.
    Hultquist JF; Binka M; LaRue RS; Simon V; Harris RS
    J Virol; 2012 Mar; 86(5):2874-7. PubMed ID: 22205746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.
    O'Connor C; Pertel T; Gray S; Robia SL; Bakowska JC; Luban J; Campbell EM
    J Virol; 2010 Jun; 84(12):5997-6006. PubMed ID: 20357094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
    Ohainle M; Kim K; Komurlu Keceli S; Felton A; Campbell E; Luban J; Emerman M
    PLoS Pathog; 2020 Apr; 16(4):e1008507. PubMed ID: 32282853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic conformational changes in the rhesus TRIM5α dimer dictate the potency of HIV-1 restriction.
    Lamichhane R; Mukherjee S; Smolin N; Pauszek RF; Bradley M; Sastri J; Robia SL; Millar D; Campbell EM
    Virology; 2017 Jan; 500():161-168. PubMed ID: 27821283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic Efficacy and Resistance Selection of a Lipopeptide Fusion Inhibitor in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    Yu D; Xue J; Wei H; Cong Z; Chen T; Zhu Y; Chong H; Wei Q; Qin C; He Y
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
    Matsuoka S; Dam E; Lecossier D; Clavel F; Hance AJ
    Retrovirology; 2009 Mar; 6():21. PubMed ID: 19254360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
    Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
    J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
    Sokolskaja E; Berthoux L; Luban J
    J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
    Stremlau M; Owens CM; Perron MJ; Kiessling M; Autissier P; Sodroski J
    Nature; 2004 Feb; 427(6977):848-53. PubMed ID: 14985764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.